Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan K C, O'Grady J, Wight D, Portmann B, Williams R
Institute of Liver Studies, King's College Hospital, London, United Kingdom.
Hepatology. 1993 Jun;17(6):1008-15.
To date only one published large series of human leukocyte antigen matching and liver allograft survival exists, and considerable confusion has arisen about the advantage or disadvantage of human leukocyte antigen matching. In the present study we have reinvestigated the relationship between human leukocyte antigen mismatch and graft survival in 466 first liver allografts, seeking to clarify the relationship between human leukocyte antigen and both acute rejection and the vanishing bile duct syndrome. In view of current criticism regarding the accuracy of serological tissue typing for human leukocyte antigen-DR, we have used both classic serology and restriction fragment length polymorphism analysis to ensure the accurate assignment of recipient DR types. In addition, we have used polymerase chain reaction amplification and allele-specific and sequence-specific oligonucleotide probes to retest the hypothesis that human leukocyte antigen class II matching may increase susceptibility to the vanishing bile duct syndrome. One-year graft survival was significantly lower in patients with zero or two human leukocyte antigen-A mismatches (52% and 63%, respectively) than in those with one human leukocyte antigen--A mismatch (69%) (p = 0.016 and p = 0.018). A similar effect of B mismatching was observed, with a 1-yr graft survival of 73% for those with one compared with 60% for those with two human leukocyte antigen-B mismatches. In contrast no correlation was found between DR mismatch and graft survival. Human leukocyte antigen class I matching appears to influence graft survival largely through the occurrence of acute rejection and the development of the vanishing bile duct syndrome.(ABSTRACT TRUNCATED AT 250 WORDS)
迄今为止,仅有一项关于人类白细胞抗原配型与肝移植存活情况的大型系列研究发表,关于人类白细胞抗原配型的利弊已引发了相当大的困惑。在本研究中,我们重新调查了466例首次肝移植中人类白细胞抗原错配与移植物存活之间的关系,旨在阐明人类白细胞抗原与急性排斥反应及胆管消失综合征之间的关系。鉴于目前对人类白细胞抗原-DR血清学组织分型准确性的批评,我们同时使用了经典血清学和限制性片段长度多态性分析来确保准确确定受者的DR类型。此外,我们使用聚合酶链反应扩增以及等位基因特异性和序列特异性寡核苷酸探针来重新检验人类白细胞抗原II类配型可能增加胆管消失综合征易感性这一假说。人类白细胞抗原-A错配数为零或两个的患者,其1年移植物存活率显著低于人类白细胞抗原-A错配数为一个的患者(分别为52%和63%对比69%)(p = 0.016和p = 0.018)。观察到B错配也有类似影响,人类白细胞抗原-B错配数为一个的患者1年移植物存活率为73%,而错配数为两个的患者为60%。相比之下,未发现DR错配与移植物存活之间存在相关性。人类白细胞抗原I类配型似乎主要通过急性排斥反应的发生和胆管消失综合征的发展来影响移植物存活。(摘要截短至250字)